Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank38
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P38
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -5.98% |
| Q2 2025 | 4.14% |
| Q1 2025 | -64.54% |
| Q4 2024 | 4.86% |
| Q3 2024 | -18.29% |
| Q2 2024 | 13.06% |
| Q1 2024 | -10.85% |
| Q4 2023 | -4.35% |
| Q3 2023 | 5.97% |
| Q2 2023 | 18.57% |
| Q1 2023 | -33.06% |
| Q4 2022 | 10.38% |
| Q3 2022 | 12.77% |
| Q2 2022 | -22.62% |
| Q1 2022 | 27.01% |
| Q4 2021 | -128.85% |
| Q3 2021 | -33.36% |
| Q2 2021 | -21.84% |
| Q1 2021 | -35.22% |
| Q4 2020 | -80.70% |
| Q3 2020 | 6.30% |
| Q2 2020 | 12.17% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q4 2016 | 0.00% |